Dilutional control of prothrombin activation at physiologically relevant shear rates

Biophysical Journal

Volumn 100, Issue 3, 2011, Pages 765-773

  Haynes, Laura M ^a   Dubief, Yves C ^b   Orfeo, Thomas ^a   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b University of Vermont   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551659654     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.12.3720     Document Type: Article

References (51)

1. Mann, K. G., M. E. Nesheim, S. Krishnaswamy. 1990. Surfacedependent reactions of the vitamin K-dependent enzyme complexes. Blood. 76:1-16.
2. Neeves, K. B., D. A. Illing, and S. L. Diamond. 2010. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys. J. 98:1344-1352.
3. Gemmell, C. H., V. T. Turitto, and Y. Nemerson. 1988. Flow as a regulator of the activation of factor X by tissue factor. Blood. 72:1404-1406.
4. Contino, P. B., H. A. Andree, and Y. Nemerson. 1994. Flow dependence of factor X activation by tissue factor-factor VIIa. J. Physiol. Pharmacol. 45:81-90.
5. Andree, H. A., P. B. Contino, Y. Nemerson. 1994. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor. Biochemistry. 33:4368-4374.
6. Schoen, P., T. Lindhout, H. C. Hemker. 1990. Continuous flow and the prothrombinase-catalyzed activation of prothrombin. Thromb. Haemost. 64:542-547.
7. Gemmell, C. H., Y. Nemerson, and V. Turitto. 1990. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex. Microvasc. Res. 40:327-340.
8. Billy, D., H. Speijer, T. Lindhout. 1995. Prothrombin activation by prothrombinase in a tubular flow reactor. J. Biol. Chem. 270:1029-1034.
9. Schoen, P., and T. Lindhout. 1991. Flow and the inhibition of prothrombinase by antithrombin III and heparin. Blood. 78:118-124.
10. Fogelson, A. L., and N. Tania. 2005. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol. Haemost. Thromb. 34:91-108.
11. Runyon, M. K., C. J. Kastrup, R. F. Ismagilov. 2008. Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J. Am. Chem. Soc. 130:3458-3464.
12. Shen, F., C. J. Kastrup, R. F. Ismagilov. 2008. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler. Thromb. Vasc. Biol. 28:2035-2041.
13. Mann, K. G., R. J. Jenny, and S. Krishnaswamy. 1988. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu. Rev. Biochem. 57:915-956.
14. Krishnaswamy, S., K. G. Mann, and M. E. Nesheim. 1986. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J. Biol. Chem. 261:8977-8984.
15. Nesheim, M. E., and K. G. Mann. 1983. The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation. J. Biol. Chem. 258:5386-5391.
16. Krishnaswamy, S., W. R. Church, K. G. Mann. 1987. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J. Biol. Chem. 262:3291-3299.
17. Petrovan, R. J., J. W. Govers-Riemslag, J. Rosing. 1998. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin. Biochemistry. 37:1185-1191.
18. 2+ ions. J. Biol. Chem. 254:88-94.
19. Hathcock, J. J. 2006. Flow effects on coagulation and thrombosis. Arterioscler. Thromb. Vasc. Biol. 26:1729-1737.
20. Nemerson, Y., and V. T. Turitto. 1991. The effect of flow on hemostasis and thrombosis. Thromb. Haemost. 66:272-276.
21. Reininger, A. J. 2008. Function of von Willebrand factor in hemostasis and thrombosis. Haemophilia. 14 (Suppl 5): 11):11-26.
22. Koyayashi, T., and K. J. Laidler. 1974. Theory of the kinetics of reactions catalyzed by enzymes attached to the interior surfaces of tubes. Biotechnol. Bioeng. 16:99-118.
23. Laidler, K. J., and P. S. Bunting. 1980. The kinetics of immobilized enzyme systems. Methods Enzymol. 64:227-248.
24. Higgins, D. L., and K. G. Mann. 1983. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J. Biol. Chem. 258:6503-6508.
25. Nesheim, M. E., F. G. Prendergast, and K. G. Mann. 1979. Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine n-(3-ethyl-1, 5-pentanediyl) amide. Biochemistry. 18:996-1003.
26. Butenas, S., T. Orfeo, K. G. Mann. 1992. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes. Biochemistry. 31:5399-5411.
27. Bajaj, S. P., and K. G. Mann. 1973. Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J. Biol. Chem. 248:7729-7741.
28. Nesheim, M. E., K. H. Myrmel, K. G. Mann. 1979. Isolation and characterization of single chain bovine factor V. J. Biol. Chem. 254:508-517.
29. Nesheim, M. E., J. B. Taswell, and K. G. Mann. 1979. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J. Biol. Chem. 254:10952-10962.
30. Heldebrant, C. M., R. J. Butkowski, K. G. Mann. 1973. The activation of prothrombin. II. Partial reactions, physical and chemical characterization of the intermediates of activation. J. Biol. Chem. 248:7149-7163.
31. Griffith, M. J., C. M. Noyes, and F. C. Church. 1985. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J. Biol. Chem. 260:2218-2225.
32. Kalb, E., S. Frey, and L. K. Tamm. 1992. Formation of supported planar bilayers by fusion of vesicles to supported phospholipid monolayers. Biochim. Biophys. Acta. 1103:307-316.
33. Tamm, L. K., and H. M. McConnell. 1985. Supported phospholipid bilayers. Biophys. J. 47:105-113.
34. Côté, H. C. F., L. Bajzar, M. E. Nesheim. 1997. Functional characterization of recombinant human meizothrombin and meizothrombin (desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition. J. Biol. Chem. 272:6194-6200.
35. Jones, K. C., and K. G. Mann. 1994. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J. Biol. Chem. 269:23367-23373.
36. Doyle, M. F., and K. G. Mann. 1990. Multiple active forms of thrombin. IV. Relative activities of meizothrombins. J. Biol. Chem. 265:10693-10701.
37. Nesheim, M. E., S. Eid, and K. G. Mann. 1981. Assembly of the prothrombinase complex in the absence of prothrombin. J. Biol. Chem. 256:9874-9882.
38. Bird, R. B., W. E. Stewart, and E. N. Lightfoot. 2002. Transport Phenomena. John Wiley & Sons, New York.
39. Brummel, K. E., S. G. Paradis, K. G. Mann. 2002. Thrombin functions during tissue factor-induced blood coagulation. Blood. 100:148-152.
40. Rosing, J., G. Tans, H. C. Hemker. 1980. The role of phospholipids and factor Va in the prothrombinase complex. J. Biol. Chem. 255:274-283.
41. Reference deleted in proof.
42. Kung, C., E. Hayes, and K. G. Mann. 1994. A membrane-mediated catalytic event in prothrombin activation. J. Biol. Chem. 269:25838-25848.
43. Deiter, S. R., and G. M. Rodgers. 2004. Thrombosis and antithrombotic therapy. In Wintrobe's Clinical Hematology. J. P. Greer, J. Foerster, J. N. Lukens, G. M. Rodgers, F. Paraskevas, and B. Glader, editors. Williams & Wilkins, Philadelphia, PA. 1413-1758.
44. Virchow, R. 1998. Thrombosis and emboli. Vascular inflammation and septic infection. In Collected Essays on Medical Science [Thrombose und Embolie. Gefassentzundung und septische Infektion. In Gesammelte Abhandlungen zur wissenschlaflichen Medicin]. Von Meidinger & Sohn, Frankfurt am Main, Germany. 219-732.
45. Reference deleted in proof.
46. Reference deleted in proof.
47. Hockin, M. F., K. C. Jones, K. G. Mann. 2002. A model for the stoichiometric regulation of blood coagulation. J. Biol. Chem. 277:18322-18333.
48. Schoen, P., and T. Lindhout. 1987. The in situ inhibition of prothrombinase-formed human α-thrombin and meizothrombin (des F1) by antithrombin III and heparin. J. Biol. Chem. 262:11268-11274.
49. Bovill, E. G., R. P. Tracy, K. G. Mann. 1995. Evidence that meizothrombin is an intermediate product in the clotting of whole blood. Arterioscler. Thromb. Vasc. Biol. 15:754-758.
50. Lim, T. K., V. A. Bloomfield, and G. L. Nelsestuen. 1977. Structure of the prothrombin-and blood clotting factor X-membrane complexes. Biochemistry. 16:4177-4181.
51. Harmison, C. R., R. H. Landaburu, and W. H. Seegers. 1961. Some physicochemical properties of bovine thrombin. J. Biol. Chem. 236:1693-1696.